Literature DB >> 27238361

Invasive cervical cancer accompanied by IgG4-related disease.

Rin Mizuno1, Yukio Yamanishi2, Satoko Uda3, Tsuyoshi Terashima4, Tatsuya Higashi5, Toshihiro Higuchi3.   

Abstract

IgG4-related disease (IgG4-RD) is a systemic disease that affects multiple organs and generates nodules or thickening. Discriminating these diseases from malignancy is important because glucocorticoid treatment is effective for patients with IgG4-RD. Coexistence of IgG4-RD with various malignant diseases has been reported, but there are few reports with regard to gynecologic malignant diseases. We encountered a case of invasive cervical cancer stage IIB accompanied by IgG4-RD. The patient was a 46-year-old woman. On pelvic magnetic resonance imaging, fluorodeoxyglucose-positron emission tomography and computed tomography, systemic multiple lymph node swelling was seen, including in the neck and the mediastinum in addition to uterine cervix. Diagnosis (and hence, appropriate treatment choice) was achieved on pathology of the submandibular gland and uterus, and analysis of serum IgG4. IgG4-RD should be suspected in patients presenting with malignancy and unusual multiple lymph node swelling.
© 2016 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  IgG4-related disease; cervical cancer; fluorodeoxyglucose-positron emission tomography; para-aortic lymph node swelling; submandibular gland

Mesh:

Substances:

Year:  2016        PMID: 27238361     DOI: 10.1111/jog.13030

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Vaginal mass: a rare manifestation of IgG4-related disease.

Authors:  Rujira Rujiwetpongstorn; Narittee Sukswai; Patou Tantbirojn; Pravit Asawanonda
Journal:  JAAD Case Rep       Date:  2022-01-06

2.  Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis.

Authors:  Songxin Yan; Yu Peng; Ziyan Wu; Hui Lu; Shengwei Mo; Xianlong Chen; Yuan Huang; Xiaomeng Li; Wen Zhang; Yongzhe Li
Journal:  RMD Open       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.